NCT04548661

Brief Summary

A surgical site infection (SSI) is an infection that occurs after a surgical procedure. Despite a variety of infection prevention strategies, SSIs still occur often and impose a significant burden on patients and the healthcare system. Intraoperative irrigation (or washing of the surgical incision before closure) may reduce SSIs, but this is uncertain. The Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation (CLEAN Wound) trial aims to determine if incisional wound irrigation with an antiseptic or salt water solution can reduce SSIs within 30 days of surgery compared to no wound irrigation. 2,500 patients aged 18 years or older who are planned to undergo an abdominal or groin open or laparoscopic procedure will be randomly assigned to incisional wound irrigation with povidone-iodine solution; or incisional wound irrigation with saline; or no irrigation and followed for 30 days after surgery to assess the incidence of SSIs, with additional outcomes collected up to 90 days after surgery. Even with significant advances in medicine over the past decades, there are still many fundamental issues in perioperative care that remain unclear due to lack of evidence. If this trial were to demonstrate that intraoperative wound irrigation reduces the incidence of SSI, these practice-changing findings could greatly benefit patients worldwide.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,701

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 14, 2020

Completed
2.9 years until next milestone

Study Start

First participant enrolled

August 2, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

2.2 years

First QC Date

September 8, 2020

Last Update Submit

December 10, 2025

Conditions

Keywords

Intraoperative incisional wound irrigation

Outcome Measures

Primary Outcomes (1)

  • Incidence of incisional surgical site infection (SSI)

    SSI will be captured through blinded central review of postoperative healthcare records and participants' self-report (using a patient-reported outcome measure, or PROM). Participants will be considered to have a SSI if they meet either the health record review criteria (if any of the following occurred: 1) wound was opened and packed; 2) wound-specific treatment with antibiotics; or 3) a diagnosis of SSI explicitly recorded in medical record by treating clinician) OR PROM criteria \[(i.e., if participant answers "Yes" to questions 2, 3 or 4: Have your surgical incision(s) been opened and packed (with gauze or bandages inside the wound) by a physician, physician assistant, nurse or nurse practitioner?; Have you been prescribed antibiotics for a problem with your surgical incision(s)?; Have you been told that your surgical incision(s) are infected by a physician, physician assistant, nurse or nurse practitioner?)\]

    Within 30 days of surgery

Secondary Outcomes (8)

  • EQ-5D-5L Quality of life

    within 30 days of surgery

  • Proportion of participants requiring wound care (received via home care services)

    within 30 days of surgery

  • Proportion of participants prescribed systemic antibiotics

    within 30 days of surgery

  • Length of stay (LOS) (in days)

    during hospitalization (up to day 30)

  • Proportion of participants with wound dehiscence requiring reoperation

    within 90 days of surgery

  • +3 more secondary outcomes

Study Arms (3)

Povidone-iodine solution

EXPERIMENTAL
Procedure: Intraoperative incisional wound irrigation with povidone-iodine solution

Saline

PLACEBO COMPARATOR
Procedure: Intraoperative incisional wound irrigation with saline

No irrigation

NO INTERVENTION

Standard incision management

Interventions

Participants randomized to the saline irrigation group will have all incisions irrigated once with 0.9% sterile normal saline delivered through a bulb syringe. Irrigation will be performed after any/all deep tissue layers are closed, prior to skin closure. The volume used will be left to the discretion of the clinician and irrigation will be administered until saturation is achieved.

Saline

Participants randomized to the povidone-iodine irrigation group will have all incisions irrigated once with povidone-iodine diluted in 0.9% sterile normal saline (to a final concentration of 5% povidone-iodine (0.5% available iodine)) delivered through a bulb syringe. The povidone-iodine irrigation should be left on for 60 seconds and then dried with sterile gauze. Irrigation will be performed after any/all deep tissue layers are closed, prior to skin closure. The volume used will be left to the discretion of the clinician and irrigation will be administered until saturation is achieved.

Povidone-iodine solution

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older;
  • Ontario Health Insurance Plan (OHIP) holder (for Ontario sites)
  • And planned to undergo any one of the following surgical procedures:
  • a) Laparotomy, CDC Class II (clean-contaminated) or III (contaminated) incision b) Laparoscopy with a planned extraction site ≥3 cm, CDC Class II (clean-contaminated) or III (contaminated) incision c) Groin incision for open or hybrid arterial procedure

You may not qualify if:

  • Contraindication to receiving povidone-iodine irrigation (i.e., known allergy)
  • Any active skin or soft tissue infection (at any site, including gangrene)
  • Known or anticipated CDC Class IV (Dirty) incision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Shared Health Manitoba

Winnipeg, Manitoba, R3A 1R9, Canada

Location

Royal Victoria Regional Health Centre

Barrie, Ontario, Canada

Location

Health Sciences North

Greater Sudbury, Ontario, P3E 5J1, Canada

Location

Hamilton Health Sciences - Juravinski Hospital

Hamilton, Ontario, Canada

Location

Kingston Health Sciences Centre

Kingston, Ontario, Canada

Location

London Health Sciences Centre

London, Ontario, Canada

Location

North York General Hospital

North York, Ontario, M2K 1E1, Canada

Location

The Ottawa Hospital

Ottawa, Ontario, K1H 8L6, Canada

Location

Mackenzie Health

Richmond Hill, Ontario, Canada

Location

Thunder Bay Regional Health Sciences Centre

Thunder Bay, Ontario, Canada

Location

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

St. Joseph's Health Centre

Toronto, Ontario, Canada

Location

St. Michael's Hospital

Toronto, Ontario, Canada

Location

Related Publications (1)

  • Roke R, Lillie E, Daneman N, Mason SA, Tomlinson G, Jiang Y, Shiroky J, Puran S, Smith DE, Abou Khalil J, Kayssi A, Serrano PE, Pinchuk B, Apte SS, Lamb T, Ma G, Vogt K, Leslie K, Mutabdzic D, Gomez D, Ladha KS, Tsang M, Bennett S, Ullah SM, Holland J, Delisle M, Smith AJ, Calderone M, Herriott J, Voltan E, Sloan B, Muaddi H, Fergusson DA, Mazer CD, Kennedy E, Marshall JC, Aarts MA, Nathens AB, Karanicolas PJ. Clinical evaluation of adults undergoing elective surgery utilizing intraoperative incisional wound irrigation (CLEAN Wound): protocol for a randomised controlled trial. BMJ Open. 2025 Jul 17;15(7):e104375. doi: 10.1136/bmjopen-2025-104375.

MeSH Terms

Conditions

Surgical Wound Infection

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Paul Karanicolas, MD PhD

    Sunnybrook Health Sciences Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Pragmatic, multicentre, participant and adjudicator-blinded, three-arm randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientist

Study Record Dates

First Submitted

September 8, 2020

First Posted

September 14, 2020

Study Start

August 2, 2023

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations